1999
DOI: 10.1111/j.1527-3466.1999.tb00005.x
|View full text |Cite
|
Sign up to set email alerts
|

MET‐88: SR Ca2+‐Uptake Stimulator for Treating Chronic Heart Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2002
2002
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(11 citation statements)
references
References 23 publications
0
11
0
Order By: Relevance
“…Thus, the non-lethal dose in female rats may be four times lower compared to male rats, a result that suggests females may have greater susceptibility to toxicity. 44 A hypothesis for this particular behavior may be the excretion rate. Forsdahl et al 22 demonstrated differences between women and men volunteers, although it is not the purpose of the study.…”
Section: Discussionmentioning
confidence: 99%
See 4 more Smart Citations
“…Thus, the non-lethal dose in female rats may be four times lower compared to male rats, a result that suggests females may have greater susceptibility to toxicity. 44 A hypothesis for this particular behavior may be the excretion rate. Forsdahl et al 22 demonstrated differences between women and men volunteers, although it is not the purpose of the study.…”
Section: Discussionmentioning
confidence: 99%
“…41,42 Two weeks of meldonium treatment reduced L-carnitine by 60% in rat heart (100 mg/kg orally daily). 44 However, humans treated with the therapeutic dose for 4 weeks exhibited only an 18% decrease in plasma L-carnitine. 50 Another study conducted by Liepinsh et al 40 administered 200 mg/kg meldonium intraperitoneally in mice once a day for 20 days.…”
Section: Therapeutic Use and Acute And Chronic Clinical Manifestationsmentioning
confidence: 99%
See 3 more Smart Citations